HomeROQ • LON
add
Roquefort Therapeutics PLC
Previous close
GBX 1.70
Day range
GBX 1.60 - GBX 1.75
Year range
GBX 1.40 - GBX 6.78
Market cap
2.63M GBP
Avg Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 219.36K | -55.96% |
Net income | -196.15K | 59.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -218.01K | 56.11% |
Effective tax rate | 23.35% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 337.11K | -37.26% |
Total assets | 5.75M | -5.55% |
Total liabilities | 861.73K | 46.30% |
Total equity | 4.89M | — |
Shares outstanding | 130.00M | — |
Price to book | 0.42 | — |
Return on assets | -9.54% | — |
Return on capital | -10.37% | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -196.15K | 59.23% |
Cash from operations | -129.60K | 69.33% |
Cash from investing | -97.00 | -113.20% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -129.28K | 69.28% |
Free cash flow | -150.82K | 50.93% |
About
Founded
2020
Website
Employees
10
